Boston—Kidney damage after CT imaging is a common complication in patients with cirrhosis. But a new study has found that treatment with N-acetylcysteine can prevent the adverse event.
The researchers also found several factors associated with the development of contrast-induced nephropathy, leading them to develop a prognostic tool they said reliably predicts the development of the adverse event in these individuals.